Gilead's oral drug succeeds in mid-stage inflammatory bowel disease trial
Gilead Sciences reported that its oral treatment eliminated symptoms in patients with inflammatory bowel disease in a mid-stage clinical trial.
2 sourcesClinical trials
00
Gilead Sciences reported that its oral treatment eliminated symptoms in patients with inflammatory bowel disease in a mid-stage clinical trial.